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Introduction
Small bowel cancer is a rare malignancy that accounts for only 2% of all gastrointestinal cancers (Paski, 2009; Pan et al, 2011) . The incidence of malignant small intestine tumors, which ranges from 0.5-1.5/100,000 in men and 0.2-1.0/100,000 in women (Parkin et al., 1992) , seems to be higher in North America and Europe than Asia (Haselkorn et al., 2005) . Most cases of small bowel cancer are diagnosed late in the course of the disease because of its vague clinical presentations (e.g. abdominal pain and abdominal discomfort), and patients who present with obvious clinical manifestations such as gastrointestinal bleeding, intestinal obstruction, or ascites are almost always diagnosed with advanced stage cancer. The most common malignancy lesions are adenocarcinoma, neuroendocrine tumor (NET), sarcomas, and small bowel lymphoma. However, the incidence of small bowel cancer is increasing, particularly for carcinoid tumor (Islam, and series discussing small bowel tumor metastasis from lung cancer (Liu et al., 2015) , cervical cancer (Qiu et al., 2015) , melanoma (Conversano et al., 2014; Kouladouros et al., 2015) , renal cell carcinoma (Ismail et al., 2015; Gorski et al., 2015) , and unknown adenocarcinoma (Alkabie et al., 2015) . On average, a small bowel cancer diagnosis is made 18 months following presentation with the first symptom. Further complicating matters is the fact that the misdiagnosis rate is as high as 56% (Zhou et al., 1999) . The overall 1-and 5-year relative survival rates (RS) are 67.9% and 47.9%, respectively (Anderson et al., 2015) . Notably, the relative 5-year survival rate has increased over the past 5 years (from 40% to 47.9%). The lowest relative survival rate occurred with adenocarcinoma, while lymphomas, sarcomas, and carcinoid tumors showed slightly better outcomes (Pan et al., 2011) .
Small bowel cancer is classified into 40 different histological subtypes (Pan et al., 2011 ). Between 1985 ,843 cases of small bowel cancer were diagnosed in the United States, with the most prevalent subtypes being carcinoid tumor (37.4%), adenocarcinoma (36.9%), lymphoma (17.3%), and sarcoma (8.4%) (Haselkorn et al., 2005) . Similarly, Zhi-Wei Zhou and colleagues (1999) reported that, of the 75 patients who were diagnosed with small bowel cancer in China between 1964 and 1995, 33 .33% had adenocarcinoma, 32.91% had leiomyosarcoma, and 26.67% had lymphoma. Not only is small bowel cancer rarer in China than in the United States, the most prevalent subtype was not even diagnosed in China.
Predisposing factors for small bowel cancer are Crohn disease, with a relative risk (RR) of 33.0 (95% CI, 15-60.9) (Canavan et al., 2006) . A recent meta-analysis demonstrated that the RR for individuals consuming the highest versus lowest category of alcohol intake was 1.51 (95% CI, 0.83-2.75). The pooled RR for individuals in the highest versus lowest category of smoking was 1.24 (95% CI, 0.71-2.17). In relation to dietary factors, high fiber intake and normal body weight may be protective, while high intake of red/processed meat and sugary drinks may increase risk (Bennett et al., 2015) .
Diagnosing small bowel cancer is difficult given the investigation relies on the location of the tumors. Upper gastrointestinal study with small bowel followthrough, ultrasonography of the whole abdomen, computed tomography (CT) scan, CT and enteroclysis/ enterography, video capsule enteroscopy (VCE), esophagogastroduodenoscopy (EGD), and balloonassisted enteroscopy (BAE) were commonly used to determine localization of the tumor and to evaluate adjacent organs (Islam et al., 2014) .
To the best of our knowledge, there are no published studies detailing small bowel cancer rates, especially in Southeast Asia, including Thailand. A better understanding of clinical, radiologic, and endoscopic markers for small bowel cancer may allow earlier diagnoses and improved patient outcomes. Therefore, we sought to study the clinical, radiologic, and endoscopic characteristics of small bowel cancer patients in patients who sought treatment at Thailand's Siriraj Hospital.
Materials and Methods
This retrospective review was approved by the Siriraj Internal Review Board (SIRB) for ethical issues. Informed consent was obtained from all patients who underwent the procedures. The data for this study were obtained from Siriraj Hospital's electronic medical record program. Adult patients were diagnosed with small bowel cancer based on pathological examination between January 2006 and December 2013 at Siriraj Hospital. Baseline characteristics, clinical findings, radiologic findings, and endoscopic findings were collected and compared between each subtype of small bowel cancer.
Tumor characteristics were analyzed using descriptive statistics, including frequencies and percentages for categorical variables. Continuous variables were reported as means, standard deviation of normally distributed variables, and median, minimum, and maximum of abnormally distributed variables. The normality of distribution of the variables was examined using the Kolmogorov-Smirnov test. The association of normally and abnormally distributed continuous variables was compared between three groups using one-way ANOVA and the Kruskal-Wallis H test, respectively. The association of categorical variables was compared between four groups using the chi-square test or Fisher's exact test.
Results
The 185 small bowel cancer patients enrolled in the study were classified into four major histological subtypes: gastrointestinal stromal tumor (GIST), adenocarcinoma, lymphoma, and other. GIST was the most common subtype, accounting for 39.5% of cases (n=73). Adenocarcinoma, lymphoma, and other were 25.9% (n=48), 24.3% (n=45), and 10.3% (n=19), respectively ( Table 1 ). The mean age at diagnosis for overall tumor was 57.6 years, with the diagnosis being more common in men. Some patients had associated cancers (e.g. colon Figure 1 . In the present study, small bowel cancer was most common between the ages of 61 and 70 years (Figure 2) .
Clinical manifestations
Of all cases, only 4.9% of the patients presented as asymptomatic. A total of 29% of patients revealed unremarkable findings on physical examination. The most common clinical manifestations related to GIST were anemia and upper gastrointestinal bleeding (24.7% and 42.5%, respectively), while weight loss and intestinal obstruction were predominant in small bowel lymphoma and adenocarcinoma for 57.8%/24.4% and 77.1%/29.2%, respectively (Table 2) . GIST, gastrointestinal stromal tumor Ultrasound examination indicated that 29 patients had an abdominal mass (Figurere 3), including 15 patients who were diagnosed with GIST, 4 who were diagnosed with adenocarcinoma, and 8 who were diagnosed with lymphoma. Overall sensitivity and specificity for diagnosis of small bowel tumor by ultrasound was not acceptable save for GIST (detection of intra-abdominal mass) (Table  3) . CT scans were performed for a total of 143 patients; findings were categorized as mass, bowel wall thickening, intestinal obstruction, intussusception biliary obstruction, or lymphadenopathy (Figure 4 ; Table 4 ).
Radiologic findings

Detection by esophagogastroduodenoscopy
Esophagogastroduodenoscopy (EGD) was performed on a total of 103 patients, with findings classified as intraluminal mass (Figure 5) , ulcer, or gastrointestinal obstruction (Table 5) .
Tumor size
Tumor size was measured for each tumor type ( Figure 6 ). The median tumor size for adenocarcinoma, lymphoma, and GIST was 4.4 cm, 6.75 cm, and 6.0 cm, respectively. The maximum size was 14.5 cm, 20 cm, and 18.5 cm, respectively, and the minimum size was 1.4 cm, 1.7 cm, and 1.5 cm, respectively.
Site of small bowel cancer
For each histological subtype, the most common histological subtype was recorded. The most common site for GIST was the jejunum, for adenocarcinoma it was the duodenum, and for lymphoma it was the ileum. (Haselkorn et al., 2005; Bilimoria et al., 2009; Cahill et al., 2014; Anderson et al., 2015) . In the present study, GIST was the most common histological subtype of small bowel cancer, followed by adenocarcinoma and lymphoma. This finding was not consistent with reports from the United States and China, which indicate that carcinoid and adenocarcinoma, respectively, are the most common histological subtypes. The incidence of small bowel cancer was more common in the United States than Asia. Unfortunately, the authors could not demonstrate the Thai incidence of small bowel malignancy in this study. However, there was evidence that the incidence of small bowel cancer increases with age, with it being most common between the ages of 61 and 70 years. This finding was similar to a U.S. report that asserted the mean age of diagnosis for any small bowel cancer to be 65 years, although sarcoma and lymphoma diagnoses tend to occur earlier. The incidence rises after the age of 40 years for all histological subtypes (Haselkorn et al., 2005) .
Discussion
Predisposing factors for small bowel cancer such as Crohn disease, excessive alcohol intake, smoking, or preexisting colorectal cancer were not found to be related in this study (data not shown). No patient in our study was previously diagnosed with Crohn disease, celiac disease, Peutz-Jeghers syndrome, familial adenomatous polyposis syndrome, or hereditary non-polyposis colorectal cancer.
The clinical manifestations of small bowel cancer are non-specific and disease onset varies, making diagnosis challenging. Patients diagnosed with adenocarcinoma or lymphoma develop symptoms earlier (2-3 mo after onset) than patients diagnosed with GIST (6 mos after onset). Further complicating diagnosis is the fact that a small subset of patients (~5%) are completely asymptomatic and about one-third of patients have normal physical examinations. Although weight loss, abdominal pain, and upper gastrointestinal bleeding are common symptoms of small bowel cancer, obstruction is a common symptom of adenocarcinoma. Moreover, anemia and upper gastrointestinal bleeding are symptoms specific to GIST and lymphoma. Interestingly, this study identified the most common site for GIST, adenocarcinoma, and lymphoma to be the jejunum, duodenum, and ileum, respectively.
There is no best technique to apply to each individual case of small bowel cancer. The authors demonstrated that ultrasonography and CT detect the disease at a sensitivity level of 67.4% and 76.2%, respectively. Barium study (small bowel follow-through) has a sensitivity of 56% to 87.4% to detect abnormal findings in the small bowel, including obstruction, ulcer, intestinal lumen narrowing, or filling defects (Ekberg and Ekholm, 1980; Martin et al., 1980; Paivansalo et al., 1988) . Recently, video capsule endoscopy (VCE) was considered an alternative non-invasive investigation for diagnosis of small bowel tumor that might be missed by other strategies (Bailey, 2006) . It had better sensitivity compared to barium study, especially for small bowel polyp detection (Mata et al., 2005) . EGD is capable of detecting small bowel cancer localized to the duodenum and proximal jejunum, but its sensitivity is only 72.7%.
In conclusion, small bowel cancers present late with non-specific symptoms. GIST is the most common histological subtype identified in Thailand, followed by adenocarcinoma and lymphoma. In this article, we have provided data detailing common locations, symptoms, tumor types, and tumor sizes associated with several common subtypes of small bowel cancer. In conjunction with the results from this study, radiologic and endoscopic techniques including EGD, ultrasound, and CT will help physicians diagnose cases of small bowel cancer earlier and with more accuracy, leading to improved patient outcomes.
